Rapport Therapeutics, Inc. RAPP
23.52 USD -0.20 (-0.86%)
Nov 6, 2026, 9:43 AM EST
23.52 Day range 23.82
22.06 52-week range 52.93
- YTD
- -22.50%
- 1 year
- -7.28%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -125.10M | -83.06M | -36.18M | -10.37M | |
| -111.48M | -78.31M | -34.79M | -10.65M | |
| -2.86 | -3.78 | -23.10 | -1.60 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 52.75M | 56.91M | 70.25M | 31.16M | |
| 512.43M | 314.93M | 155.42M | 31.60M | |
| 27.78M | 9.51M | 14.48M | 12.10M | |
| 11.48M | 1.48M | 2.15M | 0 | |
| 484.65M | 305.43M | -25.63M | -10.06M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -87.47M | -64.83M | -27.18M | -3.24M | |
| -187.47M | -170.14M | -78.86M | -5.28M | |
| 270.79M | 221.63M | 145.14M | 39.69M | |
| -616.00K | -2.40M | -1.64M | -284.00K | |
| -4.16M | -13.34M | 39.09M | 31.16M |